Contact
Biography
Adrian graduated with first class honours from the University of Leeds in 1997 before moving to London to study for a PhD at Kings College in Professor Michael Marber’s laboratory at the Department of Cardiology. Following his PhD, Adrian moved to the Protein Phosphorylation laboratory at CRUK’s London Research Institute (headed by Professor Peter Parker), where he first became fascinated by the process of cell division. He subsequently moved to UMC Utrecht, in The Netherlands, to study the role of protein kinases during mitosis in the lab of Professor Geert Kops. Adrian relocated back to the UK in March 2013 to set up his own lab in Dundee studying the spatial regulation of mitotic signalling networks.
Research
In the lab we address fundamental questions about chromosome segregation in an effort to understand why this process goes wrong so frequently in tumour cells. We also focus on some basic cell signalling concepts that have widespread implications outside of cell division. In particular, we aim to uncover how kinases and phosphatases work together to control signal responses. This is important because this "signal integration" allows binary switch like responses to control complex biological outputs.
We use a range of approaches to tackle these problems, including quantitative cell biology, synthetic biology, biochemistry and computation modelling. However, much of our day to day work involves single cell assays and microscopy: Seeing is believing.
For further information including an up-to-date list of project please visit: www.SaurinLab.com
Teaching
I currently teach on the Cancer Biology modules for 3rd and 4th year undergraduate students. I also teach on the MRes and MSci postgraduate courses.
Stories
News
We would like to extend our warmest congratulations to our School of Medicine colleagues who have been promoted recently.
News
Over the past two weeks, the University of Dundee has been celebrating graduation. Last week, the graduands from 2022 crossed the stage at the Caird Hall to receive their degrees.
Press release
University of Dundee researchers have discovered that a new type of anti-cancer drug that stops tumour cells from dividing can have long-lasting effects by causing “catastrophic” DNA damage to cells.